SMC backs drug for male urinary symptoms in Scotland
The Scottish Medicines Consortium has approved solifenacin 6mg/tamsulosin 0.4mg (Vesomni) for use in NHS Scotland.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units